Back | Next |
home / stock / catb / catb message board
Subject | By | Source | When |
---|---|---|---|
Buying volume showing up. | slow_feet | investorshub | 12/11/2020 5:36:03 PM |
* * $CATB Video Chart 12-02-2020 * * | ClayTrader | investorshub | 12/02/2020 9:25:14 PM |
Looking good! Heading north! | Spanked-It | investorshub | 12/02/2020 1:15:48 PM |
Whats up with the PM move? | stocksrising | investorshub | 12/02/2020 1:02:23 PM |
This is my favorite stock right now! Check | AaronTrades | investorshub | 11/11/2020 7:59:13 PM |
1.56$ CATB on watch | TheFinalCD | investorshub | 10/27/2020 10:28:30 PM |
Talk about oversold - RSI 8 on 90 | ErnieBilco | investorshub | 10/27/2020 10:27:07 PM |
* * $CATB Video Chart 10-27-2020 * * | ClayTrader | investorshub | 10/27/2020 9:12:12 PM |
$1.56 vs. $2.78 cash & equ | 0210 | investorshub | 10/27/2020 8:40:03 PM |
added 1.50s to my 1.70s. | 0210 | investorshub | 10/27/2020 7:32:22 PM |
Grabbed the falling knife here. | ErnieBilco | investorshub | 10/27/2020 2:27:08 PM |
Added for bounce this a.m... | Liquid1974 | investorshub | 10/27/2020 1:28:08 PM |
Guess nobody knows whats up yet | doolz | investorshub | 10/01/2020 8:46:06 PM |
WHATs going on with this Co.? | stocksrising | investorshub | 08/24/2020 2:17:17 AM |
Did I see someone bought 159000 shares!!!!!! | Chrism0000 | investorshub | 01/31/2020 2:25:23 AM |
Phase 3 trials underway to be completed in | nole92 | investorshub | 12/13/2019 12:29:50 AM |
Edasalonexent (formerly $CAT-1004) is an oral and small | nole92 | investorshub | 12/13/2019 12:26:40 AM |
News: $CATB Catabasis Pharmaceuticals to Present the MoveDMD | whytestocks | investorshub | 09/27/2019 3:27:13 PM |
News: $CATB Catabasis Pharmaceuticals Presents Preclinical Data Showing | whytestocks | investorshub | 06/21/2019 5:40:37 PM |
News: $CATB Catabasis Pharmaceuticals to Present at Upcoming | whytestocks | investorshub | 06/18/2019 6:20:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Catabasis Pharmaceuticals Inc. Company Name:
CATB Stock Symbol:
NASDAQ Market:
Catabasis Pharmaceuticals Inc. Website:
-- Astria Reflects Company’s Patient-Focused Mission -- -- Promising Lead Program STAR-0215 is in Preclinical Development to Prevent Attacks in Hereditary Angioedema -- -- Company to Begin Trading Under New Ticker Symbol ATXS on September 9 -- Cataba...
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “We are focused on advancing the development of our lead program, QLS-215, as a differe...